220 likes | 235 Views
Global humanized mice model market is projected to grow at a CAGR of more than 10% during 2020 - 2025. The global humanized mice model market is driven by continuous research and development activities in pharmaceutical companies across the globe. In addition to this, increasing investments for research in laboratories and institutes is positively impacting the growth of market.https://bit.ly/3fir8GB
E N D
2015 – 2025 GLOBAL HUMANIZED MICE MODEL MARKET FORECAST & OPPORTUNITIES www.techsciresearch.com MARKET INTELLIGENCE . CONSULTING
Scope of Report Product of Interest (POI): Humanized Mice Model Global humanized mice model market is projected to grow at a CAGR of more than 10% during 2020 - 2025. The global humanized mice model market is driven by continuous research and development activities in pharmaceutical companies across the globe. In addition to this, increasing investments for research in laboratories and institutes is positively impacting the growth of market. Market Segmentation APPLICATION TYPE SERVICE Year Range Immuno-Oncology Cell-line Breeding • • • Studies transplantation model Model In-Licensing • Review Period Diabetes Studies Genetic Testing Patient based • • • Cardiovascular Studies Other Services xenografts • • 2015 – 2018 Central Nervous Genetically Engineered • • Base Year System (CNS) Studies Mice Other Type Studies Others • • 2019 IMMUNE CHECKPOINTS PD-1 REGION END USER Estimated Year Asia-Pacific • • Companies • 2020 Europe • CTLA-4 • (Pharmaceutical, North America • CD-39 • BioService) Forecast Period Rest of World • Others • Academic and • 2021 – 2025 Research Institutes Contract Research • Organizations 2
Table of Contents S. No. Contents Page No. 1. Product Overview (Definition of product and major terminologies used in the report) Research Methodology (Detailed description of the methodology used to conduct the research, Raw data backup, list of all secondary sources, List of respondents for primary surveys) 2. 3. Impact of COVID-19 on Global Humanized Mice Model Market 4. Executive Summary 5. Voice of Customer 5.1. Factors Influencing Purchase Decision 5.2. Brand Recall 5.3. Challenges/Unmet Needs 6. Global Humanized Mice Model Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Service (Breeding, Model In-Licensing, Genetic Testing, Other Services) By Type (Cell-line transplantation model, Patient based xenografts, Genetically Engineered Mice, Others) By Application (Immuno-Oncology Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Other Type Studies) 6.2.2. 6.2.3. 6.2.4. By Immune Checkpoints (PD-1, CTLA-4, CD-39, Others) By End User (Companies, Academic and Research Institutes, Contract Research Organizations) 6.2.5. 6.2.6. By Region (Asia-Pacific, Europe, North America, Rest of the World) 3
Table of Contents S. No. Contents Page No. 6.2.7. By Company 6.3. Product Market Map 7. Asia-Pacific Humanized Mice Model Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Service 7.2.2. By Type 7.2.3. By Application 7.2.4. By Immune Checkpoints 7.2.5. By End User 7.2.6. By Country (China, India, Australia, Japan, South Korea) 7.3. Asia-Pacific: Country Analysis 7.3.1. China Humanized Mice Model Market Outlook 7.3.1.1. Market Size & Forecast By Value 7.3.1.1.1. 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Service 7.3.1.2.2. By Type 7.3.1.2.3. By Application 4
Table of Contents S. No. Contents Page No. 7.3.1.2.4. By End User 7.3.2. India Humanized Mice Model Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Service 7.3.2.2.2. By Type 7.3.2.2.3. By Application 7.3.2.2.4. By End User 7.3.3. Australia Humanized Mice Model Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Service 7.3.3.2.2. By Type 7.3.3.2.3. By Application 7.3.3.2.4. By End User 7.3.4. Japan Humanized Mice Model Market Outlook 7.3.4.1. Market Size & Forecast By Value 7.3.4.1.1. 5
Table of Contents S. No. Contents Page No. 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Service 7.3.4.2.2. By Type 7.3.4.2.3. By Application 7.3.4.2.4. By End User 7.3.5. South Korea Humanized Mice Model Market Outlook 7.3.5.1. Market Size & Forecast By Value 7.3.5.1.1. 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Service 7.3.5.2.2. By Type 7.3.5.2.3. By Application 7.3.5.2.4. By End User 8. Europe Humanized Mice Model Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Service 8.2.2. By Type 8.2.3. By Application 6
Table of Contents S. No. Contents Page No. 8.2.4. By Immune Checkpoints 8.2.5. By End User 8.2.6. By Country (France, Germany, United Kingdom, Italy, Spain) 8.3. Europe: Country Analysis 8.3.1. France Humanized Mice Model Market Outlook 8.3.1.1. Market Size & Forecast By Value 8.3.1.1.1. 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Service 8.3.1.2.2. By Type 8.3.1.2.3. By Application 8.3.1.2.4. By End User 8.3.2. Germany Humanized Mice Model Market Outlook 8.3.2.1. Market Size & Forecast By Value 8.3.2.1.1. 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Service 8.3.2.2.2. By Type 8.3.2.2.3. By Application 8.3.2.2.4. By End User 7
Table of Contents S. No. Contents Page No. 8.3.3. United Kingdom Humanized Mice Model Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Service 8.3.3.2.2. By Type 8.3.3.2.3. By Application 8.3.3.2.4. By End User 8.3.4. Italy Humanized Mice Model Market Outlook 8.3.4.1. Market Size & Forecast By Value 8.3.4.1.1. 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Service 8.3.4.2.2. By Type 8.3.4.2.3. By Application 8.3.4.2.4. By End User 8.3.5. Spain Humanized Mice Model Market Outlook 8.3.5.1. Market Size & Forecast By Value 8.3.5.1.1. 8.3.5.2. Market Share & Forecast 8
Table of Contents S. No. Contents Page No. 8.3.5.2.1. By Service 8.3.5.2.2. By Type 8.3.5.2.3. By Application 8.3.5.2.4. By End User 8.3.6. Russia Humanized Mice Model Market Outlook 8.3.6.1. Market Size & Forecast By Value 8.3.6.1.1. 8.3.6.2. Market Share & Forecast 8.3.6.2.1. By Service 8.3.6.2.2. By Type 8.3.6.2.3. By Application 8.3.6.2.4. By End User 9. North America Humanized Mice Model Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Service 9.2.2. By Type 9.2.3. By Application 9.2.4. By Immune Checkpoints 9
Table of Contents S. No. Contents Page No. 9.2.5. By End User 9.2.6. By Country (United States, Canada, Mexico) 9.3. North America: Country Analysis United States Humanized Mice Model Market Outlook 9.3.1. 9.3.1.1. Market Size & Forecast By Value 9.3.1.1.1. 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Service 9.3.1.2.2. By Type 9.3.1.2.3. By Application 9.3.1.2.4. By End User 9.3.2. Canada Humanized Mice Model Market Outlook 9.3.2.1. Market Size & Forecast By Value 9.3.2.1.1. 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Service 9.3.2.2.2. By Type 9.3.2.2.3. By Application 9.3.2.2.4. By End User 9.3.3. Mexico Humanized Mice Model Market Outlook 10
Table of Contents S. No. Contents Page No. 9.3.3.1. Market Size & Forecast By Value 9.3.3.1.1. 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Service 9.3.3.2.2. By Type 9.3.3.2.3. By Application 9.3.3.2.4. By End User 10. Rest of World Humanized Mice Model Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Service 10.2.2. By Type 10.2.3. By Application 10.2.4 By Immune Checkpoints 10.2.5. By End User 10.2.6. By Country (Brazil, South Africa, Israel) 10.3. Rest of World: Country Analysis 10.3.1. Brazil Humanized Mice Model Market Outlook 10.3.1.1. Market Size & Forecast 11
Table of Contents S. No. Contents Page No. By Value 10.3.1.1.1 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Service 10.3.1.2.2. By Type 10.3.1.2.3. By Application 10.3.1.2.4. By End User 10.3.2. South Africa Humanized Mice Model Market Outlook 10.3.2.1. Market Size & Forecast By Value 10.3.2.1.1 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Service 10.3.2.2.2. By Type 10.3.2.2.3. By Application 10.3.2.2.4. By End User 10.3.3. Israel Humanized Mice Model Market Outlook 10.3.3.1. Market Size & Forecast By Value 10.3.3.1.1 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Service 10.3.2.2.2. By Type 12
Table of Contents S. No. Contents Page No. 10.3.2.2.3. By Application 10.3.2.2.4. By End User 11. Market Dynamics (This chapter assesses the major demand drivers and restraints.) 11.1. Drivers 11.2. Challenges Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development) 12. 13. Competitive Landscape 13.1. Competition Outlook 13.2. Company Profiles 13.2.1. Company Details 13.2.2. Products & Services 13.2.3. Financials (As Reported) 13.2.4. Key Market Focus and Geographical Presence 13.2.5. Planned Investments 13.2.6. Market Positioning 13.3. Leading Players Profiled Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share) 14. 15. About Us & Disclaimer 13
RESEARCH METHODOLOGY RESEARCH METHODOLOGY
Research Methodology Market Profiling Data Analysis Data Data Developing List of Respondents Formulating Questionnaire Collection Validation In-depth secondary research was conducted to determine top players in the global humanized mice modelmarket, overall market size and segmental market size. The data was scrutinized using MS-Excel, statistical tools and internal proprietary database to obtain qualitative and quantitative insights about the global humanized mice modelmarket. Data obtained as a result of primary and secondary research was validated through rigorous triangulation. TechSci conducted interviews with industry experts and industry players for data collection and verification. In order to conduct industry experts’ interviews, TechSci formulated a detailed discussion guide. List of industry players and industry specialists was developed. Primary Research Desk Research Company Analysis ✓ ✓ Recent Developments Market Changing Aspects/Dynamics Government Policies Conclusion ✓ ✓ Market Participants Key Strengths ✓ Identifying Key Opinion Leaders Questionnaire Design In-depth Interviews Actionable Insights Data Filter & Analysis Business Solution Research & Intelligence Data Collection ✓ ✓ ✓ ✓ Primary Research Secondary Research Paid Sources LinkedIn TechSci Internal Database Company Websites Company Annual Reports White Paper Study Financial Reports Investor Presentations Regulatory Body Associations, etc. Factiva Hoovers ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 15
Research Methodology Baseline Methodology Our dedicated team of industry experts has monitored and analyzed various aspects of the global humanized mice model market. The team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as continuous research and development activities in pharmaceutical companies. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global humanized mice model market. Methodology Followed for Calculation of Market Size: Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through exhaustive • secondary research and primary surveys, with various key opinion leaders/stakeholders, such as humanized mice model companies, channel partners, market influencers & end-users, industry experts, and other industry participants. The team interviewed more than 15 – 20 humanized mice model companies, 100 – 120 end-users, and 15 – 20 industry experts and other value • chain stakeholders in the global humanized mice model market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2015- 2019. 16
Research Methodology Respondents were asked about the current and future market growth rates, market shares by service, by type, by application, by immune • checkpoints, by end user, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders. Methodology Followed for Calculation of Market Shares: Market share by service, by type, by application, by immune checkpoints, by end user, by company and by region were calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of humanized mice model market. The final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers. Methodology Followed for Forecasting: TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in • SPSS/Tableau Software. Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global humanized • mice model market, TechSci Research used various forecast techniques such as: Moving Average ✓ Time Series Analysis ✓ Regression Analysis ✓ Econometric and Judgmental Analysis ✓ 17
Research Methodology TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million. Partial List of Companies Interviewed Key Secondary Sources Charles River Laboratories, International, Inc. World Bank • • The Jackson Laboratory TechSci Research Proprietary Database & Knowledge Repository • • Gempharmatech Co Ltd Company Annual Reports • • Taconic Biosciences, Inc. Industry Magazines • • Envigo (Harlan Laboratories, Inc.) Industry Reports • • Laboratory Corporation of America Holdings News Dailies • • Janvier Labs Credible Paid Databases • • Trans Genic, Inc. • Genoway • Creative Biolabd • Horizon Discovery Group • Ingenious Targeting Laboratory • Biocytogen • Taconic Biosciences • 18
Industry Brief According to TechSci Research report, “Global Humanized Mice Model Market By Service, By Type, By Immune Checkpoints, By Application, By End-user, By Region, Competition, Forecast & Opportunities, 2025”, the global humanized mice model market is projected to grow at a CAGR of 10% during the forecast period on account of expanding pipeline of pharmaceutical and biopharmaceutical companies across the globe. Besides, growing application of mice model for research purpose such as for immunology and inflammation studies, central nervous system studies, among others, is further expected to fuel the market growth. Moreover, growing rising demand for mice model in cancer research so that genetic basis of tumor development and cancer progression can be studied, is further driving the market. However, there are certain factors that might act as major impediments to the growth of global mice model market during the forecast period such as growing concern for the wellbeing of animals coupled with increasing awareness pertaining to animal rights. Based on the application, the market is segmented into immune-oncology, central nervous system, cardiovascular, diabetes and others. The immune-oncology segment accounted for the largest market share in 2019 and the segment is expected to maintain its market dominance during the forecast period as well due to the growing rate of cancer cases and increasing investments on immune-oncology research. Based on type, the market is fragmented into cell line transplantation model, patient derived xenografts, genetically engineered mouse model and others. Out of these segments, the cell transplantation model segment dominated the market until 2019, genetically engineered mouse model and patient derived xenografts segments. Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd, Horizon Discovery Group, Ingenious Targeting Laboratory, Biocytogen, Taconic Biosciences are some of the leading players operating in global humanized mice model market. “North America is expected to dominate the humanized mice model market during the forecast period owing to surging focus on biomedical research in the region, predominantly in the United States. Additionally, rising demand for monoclonal antibody production is further expected to spur the market growth.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. 19
Sample Data - Snapshot Figure XX: Global Humanized Mice Model Market Size, By Value (USD Million), 2015-2025F 15.00 14.00 13.00 12.00 11.00 10.00 9.00 8.00 7.00 6.00 5.00 CAGR By Value XX% CAGR By Value YY% 2015 2019 2020E 2025F By Value (USD Million) North America Humanized Mice Model Market Share, By Service, By Value, 2015–2025F Breeding Model In-Licensing Genetic Testing Other Services 25% 25% 25% 25% 2025F 25% 25% 25% 25% 2024F 25% 25% 25% 25% 2023F 25% 25% 25% 25% 2022F 25% 25% 25% 25% 2021F 25% 25% 25% 25% 2020E 25% 25% 25% 25% 2019 25% 25% 25% 25% 2018 25% 25% 25% 25% 2017 25% 25% 25% 25% 2016 25% Canada Humanized Mice Model Market Share, By Type, By Value, 2015–2025F 25% 25% 25% 2015 Cell-line transplantation model Patient based xenografts Genetically Engineered Mice Others 30% 20% 30% 20% 2025F 30% 20% 30% 20% 2024F 30% 20% 30% 20% 2023F 30% 20% 30% 20% 2022F 30% 20% 30% 20% 2021F 30% 20% 30% 20% 2020E 30% 20% 30% 20% 2019 30% 20% 30% 20% 2018 30% 20% 30% 20% 2017 30% 20% 30% 20% 2016 30% 20% 30% 20% 2015 20
Report Ordering Report Name: GLOBAL HUMANIZED MICE MODEL MARKET FORECAST & OPPORTUNITIES 2015 – 2025 License Type Price Single User License $4450 Multi-User License $5450 Custom Research License $9450 To View Sample OR Purchase Report 21
About Us & Disclaimer TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality reports. The proprietary forecasting Modes use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market. Related Reports Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025 • Global Electronic Skin Patches Market By Genetic Information (Cardiovascular Monitoring, Wireless Inpatient Monitoring, Diabetes Management, Iontophoresis Skin patches, Sweat Sensing), By Material (Silicon Based, Polymer Based and Others), By Type (Disposable and Reusable), By End User (Hospitals, Ambulatory Surgical Centers and Others), By Region, Forecast & Opportunities, 2025 • TechSci Research – North America 708 Third Avenue, Manhattan, New York, United States Tel: +1- 646- 360- 1656 Email: sales@techsciresearch.com www.techsciresearch.com TechSci Research – Europe 54, Old brook, Bretton, Peterborough, United Kingdom Email: sales@techsciresearch.com www.techsciresearch.com TechSci Research – Asia-Pacific B – 44, Sector – 57, Noida, National Capital Region, U.P. - India Tel: +91-120-4523900 Email: sales@techsciresearch.com www.techsciresearch.com Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.